•  
  •  
  •  
  •  

2026-07-21 04:38:24

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • RITES & MECON sign MoU to explore business avenues
  • California Software Company Q1 FY27 Results: Consolidated Net Profit Surges 2,071% YoY to ₹4.19 Crore; Revenue Up 329%
  • Swastika Investmart Q1 FY27 Results: Consolidated Net Profit Rises 14.5% YoY to ₹3.76 Crore; Operational Revenue Up 10%
  • Golden Legand Leasing and Finance Q1 FY27 Results: Net Profit Drops 88.8% YoY to ₹54.89 Lakh Amid Top-Line Contraction
  • Authum Investment & Infrastructure Q1 FY27 Net Profit Rises 17.5% YoY to ₹1,108 Crore; Total Income Up 21.3%

Keywords Selected:  Licensing

Stock Report

  • Zydus' new drug discovery, 'Desidustat' licensed to China Medical System Holdings receives approval from NMPA of China
  • Lupin and Galenicum Sign License and Supply Agreement for Semaglutide in 23 Countries
  • Biocon Ltd signs out-licensing agreement with Ajanta to market Semaglutide in 26 countries
  • Venus Remedies Marks Completion of AMR Licensing Milestones with Final Rs. 11 Crore Payment
  • Zydus and Synthon entered into exclusive licensing and supply agreement for Ozanimod Capsules for the U.S. market
  • Shilpa Medicare announces Strategic Partnership with Orion Corporation for Recombinant Human Albumin for European Market
  • Suprajit Announces Licensing and Technology Transfer Agreement with Blubrake for Next Generation Anti-lock Braking System
  • Biocon Ltd partners with Tabuk Pharmaceuticals to commercialize its Glucagon-like peptide-1 products in the Middle East region
  • Zydus announces exclusive licensing and supply agreement for two Gadolinium based MRI injectable, contrast agents in the US
  • Biocon Ltd signs an exclusive licensing and supply agreement for generic Ozempic commercialization in Brazil with Biomm S.A.
  • Zydus and Synthon enter into an exclusive licensing and supply agreement for Palbociclib Tablets for the US market
  • Aurobindo announces signing of voluntary license with Medicines Patent Pool for Cabotegravir Long Acting Injectable for HIV pre-exposure prophylaxis for 90 countries including India

Latest Post

  • RITES & MECON sign MoU to explore business avenues
  • California Software Company Q1 FY27 Results: Consolidated Net Profit Surges 2,071% YoY to ₹4.19 Crore; Revenue Up 329%
  • Swastika Investmart Q1 FY27 Results: Consolidated Net Profit Rises 14.5% YoY to ₹3.76 Crore; Operational Revenue Up 10%
  • Golden Legand Leasing and Finance Q1 FY27 Results: Net Profit Drops 88.8% YoY to ₹54.89 Lakh Amid Top-Line Contraction
  • Authum Investment & Infrastructure Q1 FY27 Net Profit Rises 17.5% YoY to ₹1,108 Crore; Total Income Up 21.3%


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025